Dylan J Martini

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

Dana Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Jun 01 2014 - Jun 01 2017

United States

Clinical Research Coordinator :: GU Oncology

Publications

Dylan J Martini, Subir Goyal, Jeffrey M Switchenko, Mary Jo Lechowicz, Pamela Blair Allen
African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center. Leukemia & lymphoma 63 (9) (2022)
Dylan J Martini, Subir Goyal, Yuan Liu, Sean T Evans, T Anders Olsen, Katherine Case, Benjamin L Magod, Jacqueline T Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M Goldman, Bassel Nazha, Wayne B Harris, Haydn T Kissick, Viraj A Master, Omer Kucuk, Bradley C Carthon, Mehmet Asim Bilen
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist 26 (10) (2021)
Dylan J Martini, Julie M Shabto, Subir Goyal, Yuan Liu, T Anders Olsen, Sean T Evans, Benjamin L Magod, Deepak Ravindranathan, Jacqueline T Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M Goldman, Bassel Nazha, Shreyas Subhash Joshi, Haydn T Kissick, Kenneth E Ogan, Wayne B Harris, Omer Kucuk, Bradley C Carthon, Viraj A Master, Mehmet Asim Bilen
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors. The oncologist 26 (12) (2021)
Jacqueline T Brown, Yuan Liu, Julie M Shabto, Dylan J Martini, Deepak Ravindranathan, Emilie Elise Hitron, Greta Anne Russler, Sarah Caulfield, Lauren Beth Yantorni, Shreyas S Joshi, Haydn T Kissick, Kenneth Ogan, Wayne B Harris, Bradley C Carthon, Omer Kucuk, Viraj A Master, Mehmet Asim Bilen
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist 26 (5) (2021)
Alexander D Karabachev, Dylan J Martini, David J Hermel, Dana Solcz, Marcy E Richardson, Tina Pesaran, Indra Neil Sarkar, Marc S Greenblatt
Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions. PloS one 15 (8) (2020)
Dylan J Martini, Yuan Liu, Viraj A Master, Robert Donald Harvey, Mehmet Asim Bilen
Reply to Body fat indices and survival in immunotherapy-treated patients with cancer. Cancer 126 (13) (2020)
Julie M Shabto, Dylan J Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline Brown, Emilie E Hitron, Greta A Russler, Sarah Caulfield, Haydn Kissick, Mehrdad Alemozaffar, Kenneth Ogan, Wayne B Harris, Viraj A Master, Omer Kucuk, Bradley C Carthon, Mehmet Asim Bilen
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer medicine 9 (8) (2020)
Dylan J Martini, Meredith R Kline, Yuan Liu, Julie M Shabto, Milton A Williams, Amir Ishaq Khan, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn T Kissick, Bradley C Carthon, Walid L Shaib, Olatunji B Alese, Rathi N Pillai, Conor E Steuer, Christina S Wu, David H Lawson, Ragini R Kudchadkar, Bassel F El-Rayes, Suresh R Ramalingam, Taofeek K Owonikoko, Robert Donald Harvey, Viraj A Master, Mehmet Asim Bilen
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer 126 (3) (2019)

Dylan J Martini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dylan J Martini